Search results
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 2 days agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
US FDA approves Merck’s pneumococcal vaccine for adults
WSAU Wausau· 2 days ago(Reuters) - Merck said on Monday the U.S. Food and Drug Administration has approved its...
AbbVie inks immune disorder drug licensing deal with China's FutureGen
AOL· 6 days agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of blockbuster arthritis drug Humira following the entry of biosimilars in the U.S. The
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled...
Fortune via Yahoo Finance· 2 days agoIn his remarks, Sanders also called out German pharmaceutical group Merck, another maker of diabetes...
AbbVie joins in latest gastrointestinal drug chase
BioPharma Dive via Yahoo Finance· 5 days agoThe Illinois-based drugmaker is following rivals like Merck, Roche, Teva and Sanofi, which have piled billions of dollars into acquisitions to gain...
Midday movers: Nvidia, Micron rise; Lennar, Tesla fall
Investing.com via Yahoo Finance· 24 hours agoMerck (MRK) stock rose 0.1% after the U.S. Food and Drug Administration approved the drugmaker’s next-generation vaccine to protect adults against the pneumococcal ...
Stocks Show Modest Gains As S&P 500 Hits All-Time High; Nvidia Reaches Two Milestones (Live Update)
Investor's Business Daily· 15 hours agoThe 5% buy zone reaches to 212.71. Dow Jones stock Merck reversed lower after the Food and Drug...
Subtle victory for Sanders in Novo spat
Politico· 19 hours agoThe FDA announced that Merit Medical Systems initiated a recall “in direct response” to another firm’s recall of unauthorized plastic syringes because they were included in some of its kits.
